“Victim celebrities,” Ralph Nader calls them, by which he means, people who have been victimized by an abusive act or policy. They often make the best political activists against it because they bring the principle down to the personal level.
But there are also “celebrity victims,” movie stars and other assorted famous faces in the popular culture. These “stars” are often put in harness by industries and advocacy groups to use their fame to push a particular political agenda, because, fame matters in this culture, they are usually on the political “side” that the media likes, and politicians bow and scrape at their very presence.
The late Christopher Reeve was the classic example in the embryonic stem cell debate. The poor man was so used—to push the false meme that embryonic stem cells were his only hope of walking again—even as adult stem cells were restoring sensation to paralyzed people in early human trials.
Ditto, Michael J. Fox who pushed embryonic stem cells and human cloning research in political ads and biological baloney advocacy as the primary answer to Parkinson’s disease, when other modalities were offering great hope. That was then. Today, he hasn’t turned against ESCR, but he has seen the light to bring a more balanced advocacy to his work. From the ABC story:
Michael J. Fox, whose turn from Parkinson’s disease patient to scientific crusader made him one of the country’s most visible advocates for stem cell research, now believes the controversial therapy may not ultimately yield a cure for his disease, he told ABC’s Diane Sawyer in an exclusive interview. There have been “problems along the way,” Fox said of stem cell studies, for which he has long advocated. Instead, he said, new drug therapies are showing real promise and are “closer today” to providing a cure for Parkinson’s disease, a degenerative illness that over time causes the body to become rigid and the brain to shut down.
“Stem cells are an avenue of research that we’ve pursued and continue to pursue but it’s part of a broad portfolio of things that we look at. There have been some issues with stem cells, some problems along the way,” said Fox, who suffers from the diseases’ telltale tics and tremors. “It’s not so much that [stem cell research has] diminished in its prospects for breakthroughs as much as it’s the other avenues of research have grown and multiplied and become as much or more promising. So, an answer may come from stem cell research but it’s more than likely to come from another area,” he said.
The “broad portfolio” isn’t new. It existed at the time of his earlier stridency. Even now, there are no human ESC trials for Parkinson’s. And human cloning hasn’t yet been reliably accomplished. But this is a significant back off by Fox.
One is tempted to be cynical. Fox’s earlier misleading TV ads were used by Democrats to demagogue their political opponents as somehow wanting to thwart CURES! CURES! CURES!, with Fox as the more than willing accomplice. Stem cells have ceased to be a potent political weapon for the Democrats, and so suddenly Fox has a more balanced understanding. How convenient.
We launched the First Things 2023 Year-End Campaign to keep articles like the one you just read free of charge to everyone.
Measured in dollars and cents, this doesn't make sense. But consider who is able to read First Things: pastors and priests, college students and professors, young professionals and families. Last year, we had more than three million unique readers on firstthings.com.
Informing and inspiring these people is why First Things doesn't only think in terms of dollars and cents. And it's why we urgently need your year-end support.
Will you give today?